Feasibility of Patient-Specific Quality Assurance Using Gamma Analysis for IMRT Plans in Laryngeal Cancer
,
Abstract
Purpose: Laryngeal cancer is a critical health issue, often treated using advanced radiation therapy techniques such as Intensity-Modulated Radiation Therapy (IMRT). The gamma index is a widely used metric for quality assurance in radiotherapy, assessing the agreement between planned and delivered dose distributions.
This study aims to evaluate the feasibility and accuracy of laryngeal IMRT treatment plans using three gamma analysis algorithms and varying evaluation parameters, including Dose Difference (DD%), and Distance-To-Agreement (DTA).
Materials and Methods: IMRT treatment plans for laryngeal cancer were generated using the Prowess Panther V5.5 Treatment Planning System (TPS). Patient-Specific Quality Assurance (PSQA) was conducted using EBT3 Gafchromic films scanned at 350 dpi and analyzed with RIT Complete 6.11 software. Dose distributions were evaluated using three gamma analysis algorithms under 3%/3 mm criteria and low-dose thresholds of 15%. Calibration of the films was performed to ensure accurate dose measurements.
Results: Gamma Passing Rates (GPR) for the laryngeal IMRT plans demonstrated high accuracy, with over 90% of pixels passing the criteria in most cases. Composite gamma analysis showed 53.89% of pixels meeting both DD and DTA criteria simultaneously, while individual evaluation revealed the impact of stricter thresholds on GPR. Subtraction analysis identified dose discrepancies, emphasizing the need for accurate calibration.
Conclusion: This study highlights the effectiveness of gamma analysis in ensuring the accuracy of IMRT treatment plans for laryngeal cancer. The findings underscore the importance of rigorous PSQA, parameter optimization, and advanced algorithms to enhance treatment precision.
2- M. E. Gamez, A. Blakaj, W. Zoller, M. Bonomi, and D. M. Blakaj, "Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management." (in eng), Cancers (Basel), Vol. 12 (No. 6), Jun 22 (2020).
3- M. A. Samuels, L. M. Freedman, and N. Elsayyad, "Intensity-modulated radiotherapy for early glottic cancer: transition to a new standard of care?" (in eng), Future Oncol, Vol. 12 (No. 22), pp. 2615-30, Nov (2016).
4- M. S. Swanson, G. Low, U. K. Sinha, and N. Kokot, "Transoral surgery vs intensity-modulated radiotherapy for early supraglottic cancer: a systematic review." (in eng), Curr Opin Otolaryngol Head Neck Surg, Vol. 25 (No. 2), pp. 133-41, Apr (2017).
5- Keyvan Jabbari, Alireza Amouheidari, and Shadi Babazadeh, "The Quality Control of Intensity Modulated Radiation Therapy (IMRT) for ONCOR Siemens Linear Accelerators Using Film Dosimetry." (in en), Iranian Journal of Medical Physics, Vol. 9 (No. 2), pp. 111-25, (2012).
6- G. A. Ezzell et al., "Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee." (in eng), Med Phys, Vol. 30 (No. 8), pp. 2089-115, Aug (2003).
7- M. Miften et al., "Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218." (in eng), Med Phys, Vol. 45 (No. 4), pp. e53-e83, Apr (2018).
8- M. Hussein, P. Rowshanfarzad, M. A. Ebert, A. Nisbet, and C. H. Clark, "A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems." (in eng), Radiother Oncol, Vol. 109 (No. 3), pp. 370-6, Dec (2013).
9- D. A. Low, W. B. Harms, S. Mutic, and J. A. Purdy, "A technique for the quantitative evaluation of dose distributions." (in eng), Med Phys, Vol. 25 (No. 5), pp. 656-61, May (1998).
10- L. Coleman and C. Skourou, "Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics." (in eng), Med Phys, Vol. 40 (No. 11), p. 111715, Nov (2013).
11- J. H. Song et al., "Gamma analysis dependence on specified low-dose thresholds for VMAT QA." (in eng), J Appl Clin Med Phys, Vol. 16 (No. 6), pp. 263-72, Nov 8 (2015).
12- T. Ju, T. Simpson, J. O. Deasy, and D. A. Low, "Geometric interpretation of the gamma dose distribution comparison technique: interpolation-free calculation." (in eng), Med Phys, Vol. 35 (No. 3), pp. 879-87, Mar (2008).
13- T. Depuydt, A. Van Esch, and D. P. Huyskens, "A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation." (in eng), Radiother Oncol, Vol. 62 (No. 3), pp. 309-19, Mar (2002).
14- V. Casanova Borca et al., "Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification." (in eng), J Appl Clin Med Phys, Vol. 14 (No. 2), p. 4111, Mar 4 (2013).
15- R. Abedi Firouzjah, A. Nickfarjam, M. Bakhshandeh, and B. Farhood, "The use of EBT3 film and Delta4 for the dosimetric verification of EclipseTM treatment planning system in a heterogeneous chest phantom: an IMRT technique." (in eng), International Journal of Radiation Research, Technical Note Vol. 17 (No. 2), pp. 355-61, (2019).
16- V. R. Gedam and A. Pradhan, "EVALUATION OF PATIENT-SPECIFIC IMRT QUALITY ASSURANCE AND POINT DOSE MEASUREMENT FOR COMPLEX HEAD AND NECK AND BRAIN CANCER USING GAFCHROMIC EBT3 FILM." (in eng), Radiat Prot Dosimetry, Vol. 199 (No. 2), pp. 164-70, Feb 15 (2023).
17- Nalbant Nalbant, N DonmezKesen, and Bilge Hatice, "Pre-Treatment Dose Verification of Imrt Using Gafchromic Ebt3 Film and 2DArray." Journal of Nuclear Medicine and Radiation Therapy, Vol. 5pp. 1-6, (2014).
18- Rooshenass Raheleh, Barough Mehdi Salehi, Gholami Somayeh, and Mohammadi Ehsan, "Dosimetric Accuracy Comparison between ACUROSE XB, AAA and PBC Dose Calculation Algorithms in EclipseTM TPS Using a Heterogeneous Phantom." Frontiers in Biomedical Technologies, Vol. 6 (No. 4), 12/30 (2018).
19- F. Falahati, A. Nickfarjam, and M. Shabani, "A Feasibility Study of IMRT of Lung Cancer Using Gafchromic EBT3 Film." (in eng), J Biomed Phys Eng, Vol. 8 (No. 4), pp. 347-56, Dec (2018).
| Files | ||
| Issue | Vol 13 No 3 (2026) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/fbt.v13i3.22745 | |
| Keywords | ||
| Laryngeal Cancer Intensity-Modulated Radiation Therapy Gamma Analysis EBT3 Film Patient-Specific Quality Assurance Radiotherapy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
